Malignant melanoma of the vulva FIGO stage I: Evaluation of prognostic factors in 43 patients with emphasis on DNA ploidy and surgical treatment

Gynecologic Oncology

Volumn 61, Issue 2, 1996, Pages 253-258

  ScheistrØen, Marit ^a   Tropé, Claes ^a   Kaern, Janne ^a   Abeler, Vera M ^a   Pettersen, Erik O ^a   Kristensen, Gunnar B ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; MELANOMA; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; VULVA CANCER; VULVECTOMY;

EID: 0030003606     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0135     Document Type: Article

References (33)

1. Morrow, C. P., and Rutledge, F. N. Melanoma of the vulva, Obstet. Gynecol. 39, 745-752 (1972).
2. Chung, A. F., Woodruff, J. M., and Lewis, J. L. Malignant melanoma of the vulva: A report of 44 cases, Obstet. Gynecol. 45, 638-646 (1975).
3. Karlen, J. R., Piver, M. S., and Barlow, J. J. Melanoma of the vulva, Obstet. Gynecol. 45, 181-185 (1975).
4. Ariel, I. M. Malignant melanoma of the female genital system: A report of 48 patients and review of the literature, J. Surg. Oncol. 16, 371-383 (1981).
5. Podratz, K. C., Gaffey, T. A., Symmonds, R. E., Johansen, K. L., and O'Brian, P. C. Melanoma of the vulva: An update, Gynecol. Oncol. 16, 153-168 (1983).
6. Jaramillo, B. A., Ganjei, P., Averette, H. E., Sevin, B.-U., and Lovecchio, J. L. Malignant melanoma of the vulva, Obstet. Gynecol. 66, 398-401 (1985).
7. Davidson, T., Kissin, M., and Westbury, G. Vulvo-vaginal melanoma - Should radical surgery be abandoned? Br. J. Obstet. Gynecol. 94, 473-476 (1987).
8. Rose, P. G., Piver, S., Tsukada, Y., and Lau, T. Conservative therapy for melanoma of the vulva, Am. J. Obstet. Gynecol 159, 52-55 (1988).
9. Bradgate, M. G., Rollason, T. P., McConcey, C. C., and Powell, J. Malignant melanoma of the vulva: a clinicopathological study of 50 women, Br. J. Obstet. Gynecol. 97, 124-133 (1990).
10. Trimble, E. L., Lewis, J. L., Williams, L. L., Curtin, J. P., Chapman, D., Woodruff, J. M., Rubin, S. C., and Hoskins, W. J. Management of vulvar melanoma, Gynecol. Oncol. 45, 254-258 (1992).
11. Tasseron, E. W. K., van der Esch, E. P., Hart, A. M. M., de la Rivière, G. B., and Aartsen, E. J. A clinicopathological study of 30 melanomas of the vulva, Gynecol. Oncol. 46, 170-175 (1992).
12. Phillips, G. L., Bundy, B. N., Okagaki, T., Kucera, P. R., and Stehman, F. B. Malignant melanoma of the vulva treated by radical hemivulvectomy, Cancer 73, 2626-2632 (1994).
13. Scheistrøen, M., Tropé, C., Kærn, J., Pettersen, E. O., Abeler, V. M., and Kristensen, G. B. Malignant melanoma of the vulva: Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients, Cancer 75, 72-80 (1995).
14. Petterson, F. Annual report on the results of treatment in gynecological cancer, Int. J. Gynaecol. Obstet. 21(Suppl.), 278-285 (1991).
15. Clark, W. H., Bernardino, E. A., and Mihm, M. C. Histogenesis and biologic behavior of human malignant melanoma of the skin, Cancer. Res. 29, 705-726 (1969).
16. Breslow, A., Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous malignant melanoma, Ann. Surg. 172, 902-908 (1970).
17. McGovern, V. J., Shaw, H. M., Milton, G. W., and McCarthy, W. H. Ulceration and prognosis in cutaneous malignant melanoma, Histopathology 6, 399-407 (1982).
18. Hedley, D. W., Friedlander, M. L., Taylor, I. W., Rugg, C. A., and Musgrove, E. A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry, J. Histochem. Cytochem. 31, 1333-1335 (1983).
19. Kaern, J., Iversen, T., Tropé, C., Pettersen, E. O., and Nesland, J. M., Flow cytometric DNA measurements in squamous cell carcinima of the vulva: An important prognostic method, Int. J. Gynecol. Cancer 2, 169-174 (1992).
20. Kaplan, E. L., Meier, P. Nonparametric estimation from incomplete observations, J. Am. Stat. Assoc. 53, 457-481 (1958).
21. Tarone, R. E., and Ware, J. On distribution-free tests for equality of survival distributions, Biometrika 64, 156-160 (1977).
22. Cox, D. R. Regression models and life tables, J. R. Stat. Soc. 34, 187-220 (1972).
23. Elias, E. G., Didolkar, M. S., Goel, I. P., Formeister, J. F., Valenzuela, L. A., Pickren, J. L., and Moore, R. H. A clinicopathologic study of prognostic factors in cutaneous malignant melanoma, Surg. Gynecol. Obstet. 144, 327-334 (1977).
24. Gilchrist, W. K., Gilbert, E., Metter, G., and Powers, D. Importance of microscopic vascular invasion in primary cutaneous malignant melanoma, Surg. Gynecol. Obstet. 145, 559-561 (1977).
25. Fidler, I. J. The biology of melanoma metastasis, J. Dermatol. Surg. Oncol. 14, 875-881 (1988).
26. Friedlander, M. L., Hedley, D. W., and Taylor, I. W. Clinical and biological significance of aneuploidy in human tumours, J. Clin. Pathol. 37, 961-974 (1984).
27. Kheir, S. M., Bines, S. D., Vonroenn, J. H., Soong, S-J., Urist, M. M., and Coon, J. S. Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma, Ann. Surg. 207, 455-461 (1988).
28. Gattuso, P., Reddy, V., Solans, E., Kathuria, S., Aranha, G. V., Jacobs, H. K., and Walloch, J. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma? Surgery 108, 702-708 (1990).
29. Bartkowiak, D., Schumann, J., Otto, F. J., Lippold, A., and Drepper, H. DNA flow cytometry in the prognosis of primary malignant melanoma, Oncology 48, 39-43 (1991).
30. Heenan, P. J., English, D. R., Holman, C. D. J., and Armstrong, B. K. The effects of surgical treatment on survival and local recurrence of cutaneous malignant melanoma, Cancer 69, 421-426 (1992).
31. McClay, E. F., and Mastrangelo, M. J., Systemic chemotherapy for metastatic melanoma. Semin. Oncol. 15, 569-577 (1988).
32. Cocconi, G., Mariangela, B., Calabresi, F., Tonat, M., Canaletti, R., Boni, C., Buzzi, F., Ceci, G., Corgna, E., Costa, P., Lottici, R., Papadia, F., Sofra, M. C., and Bacchi, M. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, N. Engl. J. Med. 327, 516-522 (1992).
33. Buzaid, A. C., and Murren, J. Chemotherapy for advanced malignant melanoma, Int. J. Clin. Res. 21, 205-209 (1992).